KLP Kapitalforvaltning AS Invests $228,000 in LifeStance Health Group, Inc. (NASDAQ:LFST)

KLP Kapitalforvaltning AS acquired a new stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) in the fourth quarter, Holdings Channel.com reports. The firm acquired 30,900 shares of the company’s stock, valued at approximately $228,000.

Several other hedge funds have also made changes to their positions in the stock. Geode Capital Management LLC raised its holdings in LifeStance Health Group by 26.8% in the 3rd quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company’s stock valued at $24,170,000 after acquiring an additional 729,794 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of LifeStance Health Group by 36.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company’s stock valued at $7,731,000 after purchasing an additional 297,723 shares during the period. SG Americas Securities LLC increased its position in shares of LifeStance Health Group by 65.7% during the fourth quarter. SG Americas Securities LLC now owns 90,355 shares of the company’s stock valued at $666,000 after purchasing an additional 35,823 shares during the period. JPMorgan Chase & Co. raised its stake in shares of LifeStance Health Group by 13.0% in the third quarter. JPMorgan Chase & Co. now owns 94,636 shares of the company’s stock valued at $662,000 after purchasing an additional 10,894 shares in the last quarter. Finally, State Street Corp lifted its position in LifeStance Health Group by 4.7% in the third quarter. State Street Corp now owns 2,750,656 shares of the company’s stock worth $19,255,000 after purchasing an additional 122,844 shares during the period. Institutional investors own 85.50% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on LFST. William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. Canaccord Genuity Group assumed coverage on shares of LifeStance Health Group in a research note on Thursday, April 3rd. They issued a “buy” rating and a $8.00 target price on the stock. Finally, The Goldman Sachs Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price target for the company in a research note on Monday, December 16th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, LifeStance Health Group has a consensus rating of “Moderate Buy” and a consensus target price of $8.50.

LifeStance Health Group Stock Down 2.0 %

Shares of NASDAQ:LFST opened at $6.51 on Tuesday. The company’s fifty day moving average is $7.44 and its 200-day moving average is $7.34. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. LifeStance Health Group, Inc. has a 52 week low of $4.64 and a 52 week high of $8.61. The company has a market capitalization of $2.50 billion, a PE ratio of -25.04 and a beta of 1.30.

Insider Activity at LifeStance Health Group

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of the company’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $6.90, for a total transaction of $130,030.50. Following the sale, the insider now directly owns 339,810 shares of the company’s stock, valued at approximately $2,344,689. This represents a 5.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 6.60% of the stock is currently owned by insiders.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.